Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis (Q34158701)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

3 references

7 August 2020

15 July 2021

25 October 2022

0 references

Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis (English)

1 reference

Europe PubMed Central

31 July 2017

1 reference

7 August 2020

liver cirrhosis

9 references

14 March 2019

23 March 2019

21 March 2019

28 September 2019

12 October 2019

18 October 2019

7 August 2020

15 July 2021

25 October 2022

1 reference

28 September 2019

1 reference

12 October 2019

hemic and immune systems

1 reference

18 October 2019

1 reference

7 August 2020

1 reference

based on heuristic

inferred from title

author name string

Wenwen Jin

1

1 reference

Europe PubMed Central

31 July 2017

Zhonghua Lin

2

1 reference

Europe PubMed Central

31 July 2017

Yongning Xin

3

1 reference

Europe PubMed Central

31 July 2017

Xiangjun Jiang

4

1 reference

Europe PubMed Central

31 July 2017

Quanjiang Dong

5

1 reference

Europe PubMed Central

31 July 2017

Shiying Xuan

6

1 reference

Europe PubMed Central

31 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

14 February 2012

10 references

Europe PubMed Central

31 July 2017

14 March 2019

23 March 2019

21 March 2019

28 September 2019

12 October 2019

18 October 2019

7 August 2020

15 July 2021

25 October 2022

BMC Gastroenterology

10 references

Europe PubMed Central

31 July 2017

14 March 2019

23 March 2019

21 March 2019

28 September 2019

12 October 2019

18 October 2019

7 August 2020

15 July 2021

25 October 2022

12

1 reference

Europe PubMed Central

31 July 2017

14

1 reference

Europe PubMed Central

31 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

9 references

Europe PubMed Central

14 March 2019

Europe PubMed Central

23 March 2019

Europe PubMed Central

21 March 2019

Europe PubMed Central

28 September 2019

Europe PubMed Central

12 October 2019

Europe PubMed Central

18 October 2019

Europe PubMed Central

7 August 2020

Europe PubMed Central

15 July 2021

Europe PubMed Central

25 October 2022

copyright status

0 references

on focus list of Wikimedia project

0 references

https://scigraph.springernature.com/pub.10.1186/1471-230x-12-14

0 references

Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: a comparative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

5 July 2018

Noninvasive assessment of liver fibrosis with combined serum aminotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

5 July 2018

Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

5 July 2018

Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

5 July 2018

Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

5 July 2018

Introduction to chronic hepatitis B infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

5 July 2018

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

5 July 2018

Development and validation of methods for assessing the quality of diagnostic accuracy studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

5 July 2018

Controversies in liver biopsy: who, where, when, how, why?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

5 July 2018

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

5 July 2018

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

5 July 2018

Histological grading and staging of chronic hepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

5 July 2018

Chronic hepatitis. An update on terminology and reporting.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

5 July 2018

Is day case liver biopsy underutilised?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

5 July 2018

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

5 July 2018

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-12-14

21 January 2018

Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-12-14

21 January 2018

Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-12-14

21 January 2018

APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-12-14

21 January 2018

Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-12-14

21 January 2018

Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-12-14

21 January 2018

Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-12-14

21 January 2018

Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-12-14

21 January 2018

Disease progression and the risk factor analysis for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-12-14

21 January 2018

Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-12-14

21 January 2018

Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-12-14

21 January 2018

Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

28 October 2018

A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

28 October 2018

Sampling variability of liver fibrosis in chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306191

28 October 2018

Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-12-14

21 January 2018

Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22333407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/22333407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-invasive models for predicting histology in patients with chronic hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/22333407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Technology evaluation: A critical step in the clinical utilization of novel diagnostic tests for liver fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22333407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing routine and serum markers of liver fibrosis in CHB patients using parallel and serial interpretation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22333407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-230X-12-14

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34158701&oldid=1758097261"